rs10496228
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001399737.1(CTNNA2):c.-134-27064A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.577 in 152,092 control chromosomes in the GnomAD database, including 26,242 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.58 ( 26242 hom., cov: 33)
Consequence
CTNNA2
NM_001399737.1 intron
NM_001399737.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.413
Publications
2 publications found
Genes affected
CTNNA2 (HGNC:2510): (catenin alpha 2) Enables actin filament binding activity. Involved in negative regulation of Arp2/3 complex-mediated actin nucleation; regulation of neuron migration; and regulation of neuron projection development. Located in cytoplasm. Implicated in complex cortical dysplasia with other brain malformations. [provided by Alliance of Genome Resources, Apr 2022]
CTNNA2 Gene-Disease associations (from GenCC):
- cortical dysplasia, complex, with other brain malformations 9Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.653 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CTNNA2 | NM_001399737.1 | c.-134-27064A>G | intron_variant | Intron 4 of 21 | NP_001386666.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.577 AC: 87763AN: 151974Hom.: 26235 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
87763
AN:
151974
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.577 AC: 87810AN: 152092Hom.: 26242 Cov.: 33 AF XY: 0.574 AC XY: 42677AN XY: 74332 show subpopulations
GnomAD4 genome
AF:
AC:
87810
AN:
152092
Hom.:
Cov.:
33
AF XY:
AC XY:
42677
AN XY:
74332
show subpopulations
African (AFR)
AF:
AC:
17608
AN:
41486
American (AMR)
AF:
AC:
9099
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
2349
AN:
3472
East Asian (EAS)
AF:
AC:
2411
AN:
5166
South Asian (SAS)
AF:
AC:
2400
AN:
4824
European-Finnish (FIN)
AF:
AC:
7051
AN:
10564
Middle Eastern (MID)
AF:
AC:
171
AN:
294
European-Non Finnish (NFE)
AF:
AC:
44777
AN:
67990
Other (OTH)
AF:
AC:
1248
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1858
3716
5573
7431
9289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1708
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.